Sep 2, 2025 06:56AM
Aug 6, 2025 07:33AM
Jul 11, 2025 07:45AM
Jul 11, 2025 07:43AM
Jun 30, 2025 07:30AM
Jun 30, 2025 07:30AM
Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
Feb 28, 2025 07:50AM
Feb 28, 2025 07:49AM
Feb 15, 2025 10:00PM
Mar 4, 2024 04:46PM
Jul 17, 2023 10:15AM
Mar 29, 2023 12:46PM
Mar 24, 2023 03:58PM BridgeBio Pharma Inc. (BBIO) Said To Attract Interest From Pharma Companies - Bloomberg
Nov 3, 2022 07:30AM
Nov 3, 2022 07:30AM
Aug 4, 2022 07:30AM
Aug 4, 2022 07:30AM
May 12, 2022 07:31AM
May 12, 2022 07:30AM
May 12, 2022 07:30AM BridgeBio Announces Exclusive License Agreement with Bristol Myers Squibb to Develop and Commercialize BBP-398, a Potentially Best-in-Class SHP2 Inhibitor, in Oncology
Mar 8, 2022 07:30AM
Mar 8, 2022 07:30AM
Mar 8, 2022 07:30AM
Feb 24, 2022 07:30AM
Feb 24, 2022 07:30AM
Nov 4, 2021 07:30AM
Aug 18, 2021 07:36AM BridgeBio Pharma Inc. (BBIO) Appoints Fred Hassan, Andrea Ellis and Douglas Dachille to its Board
Aug 18, 2021 07:30AM
Aug 5, 2021 07:30AM
Jun 29, 2021 04:59AM
Jun 28, 2021 07:10PM
Jun 28, 2021 07:10PM
May 6, 2021 07:30AM
May 6, 2021 07:30AM BridgeBio Pharma, Inc. Reports First Quarter 2021 Financial Results And Business Update
Feb 25, 2021 07:30AM
Feb 25, 2021 07:30AM
Jan 26, 2021 08:30AM
Jan 26, 2021 08:30AM
Jan 19, 2021 04:01PM
Jan 19, 2021 04:01PM
Jan 13, 2021 04:30PM BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Announce January 21, 2021 Election Deadline for Merger
Jan 13, 2021 04:30PM
Jan 4, 2021 11:42AM
Jan 4, 2021 07:30AM
Jan 4, 2021 07:30AM
Dec 11, 2020 10:13AM
Nov 5, 2020 07:30AM
Nov 5, 2020 07:30AM BridgeBio Pharma, Inc. Reports Third Quarter 2020 Financial Results And Business Update
Oct 27, 2020 05:00PM

1,154,889 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All